Azelastine Hydrochloride

盐酸氮卓斯汀

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameAzelastine Hydrochloride
Drug Alias NameAzelastinum盐酸氮斯汀azelastina盐酸氮斯丁盐酸氮革斯汀 +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial +[6] 
Global Approved IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1996/11/01
Country/TerritoryBulgariaCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare LlcSandozViatris Gmbh & Co Kg
Inactive CompaniesRising Pharma Holdings IncMeda AbBayer AG
Active IndicationsRhinitis, Allergic, SeasonalRhinitis, AllergicNasal Obstruction
Inactive IndicationsConjunctivitis, AllergicRhinitis, Allergic, PerennialRhinitis

Other Information

ATC CodeR01AC03R06AX19S01GX07
Related LinksWikipediaDrugBankKEGG